• Aclacinomycin A: Precision DNA Damage and Apoptosis Workflow

  2026-06-03

  Aclacinomycin A (Aclarubicin) empowers researchers with reproducible, quantitative DNA damage and apoptosis assays, leveraging dual topoisomerase inhibition for dissecting cellular stress responses. This guide translates the latest nucleolar DNA damage research into practical workflows, actionable troubleshooting, and strategic protocol enhancements for high-impact cancer and cell biology studies.

• EDTA-Free Protease Inhibitors: Powering Translational OXPHOS

  2026-06-02

  Explore how advanced EDTA-free protease inhibitor cocktails are transforming the extraction and stabilization of proteins for dual-genome OXPHOS disruption studies, and discover strategic guidance for translational researchers targeting tumor metabolism.

• Silybin A in Silymarin: Optimizing Liver Disease Research Pr

  2026-06-02

  Unlock the full potential of Silybin A, the bioactive heart of Silymarin, with practical workflows and troubleshooting strategies tailored for liver disease, metabolic, and inflammation research. Discover how APExBIO’s high-purity Silybin A streamlines assay reproducibility, supports advanced mechanistic studies, and outperforms generic silibinin products.

• Oteseconazole (VT-1161): Optimizing Antifungal Assays for Ca

  2026-06-01

  Oteseconazole (VT-1161) delivers highly selective, potent inhibition of Candida species—even fluconazole-resistant strains—enabling robust, reproducible antifungal assays. This guide translates recent research into actionable workflows, comparative insights, and troubleshooting strategies for infection models and drug resistance studies.

• Imidazoline Antagonists Stimulate Insulin via K+ Channel Blo

  2026-06-01

  This study demonstrates that imidazoline antagonists of α2-adrenoceptors increase insulin secretion in vitro by targeting ATP-sensitive K+ channels in pancreatic β-cells, rather than by adrenergic antagonism. The mechanistic insight informs future antidiabetic drug development and provides a refined framework for ion channel research in metabolic regulation.

• Gamma-linolenic Acid: Optimized Workflows for Anti-Inflammat

  2026-05-31

  Gamma-linolenic acid (GLA) is redefining anti-inflammatory and apoptosis research with its unique mechanistic profile and reproducible efficacy. This article delivers actionable workflows, troubleshooting strategies, and advanced protocols leveraging high-purity GLA from APExBIO for robust experimental results.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Biomolec

  2026-05-30

  Cy3 NHS ester (non-sulfonated) enables precise labeling of proteins, peptides, and oligonucleotides via amine-reactive chemistry, supporting sensitive detection in biomedical imaging and analytical workflows. It is not suited for fully aqueous protocols or for labeling delicate proteins that cannot tolerate organic co-solvents. Researchers should optimize solvent conditions and follow storage guidelines to ensure labeling efficiency and reproducibility.

• Cy3 NHS Ester (Non-Sulfonated): Technical Guide for Labeling

  2026-05-29

  Cy3 NHS ester (non-sulfonated) provides a reliable solution for covalent labeling of amino groups in proteins, peptides, and oligonucleotides, especially for applications requiring orange fluorescence (excitation 555 nm, emission 570 nm). It is best suited for workflows compatible with organic co-solvents and should not be used with delicate proteins intolerant to DMSO or DMF. Careful protocol setup and QC are essential for reproducible performance.

• LMO2–LDB1 Complex Drives AML Progression via Transcriptional

  2026-05-29

  This study reveals that the interaction between LMO2 and LDB1 is essential for acute myeloid leukemia (AML) cell proliferation and survival. By dissecting their mechanistic partnership, the research identifies the LMO2/LDB1 complex as a key oncogenic driver and a promising therapeutic target, with direct implications for epigenetic and DNA fidelity research in leukemia.

• Atropo-Enantioselective Suzuki Coupling for Chiral Biaryl Sy

  2026-05-28

  This study pioneers the catalytic asymmetric synthesis of axially chiral biaryl compounds with antimitotic properties using an atropo-enantioselective Suzuki cross-coupling. The work presents both methodological advances and mechanistic insights relevant for chemical biology and structure-activity research.

• Fosinopril Sodium: Next-Gen ACE Inhibitor in Cardiovascular

  2026-05-28

  Fosinopril sodium, a third-generation ACE inhibitor, offers dual renal-hepatic elimination and robust zinc ion binding, enabling advanced hypertension and cardiovascular disease modeling. This guide delivers stepwise workflows, troubleshooting strategies, and actionable protocol enhancements to maximize reproducibility and translational value in preclinical studies.

• Baicalein: Applied Protocols for Cancer and Inflammation Res

  2026-05-27

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) enables highly targeted inhibition of cancer cell proliferation and inflammation pathways via 12-LOX blockade. This guide offers hands-on protocol enhancements, troubleshooting insights, and contextualizes recent mechanistic advances for maximizing assay reproducibility and translational impact.

• sEH Suppresses Nrf2 to Drive Osteoclastogenesis in Osteoporo

  2026-05-27

  This study uncovers a novel liver-bone axis in osteoporosis, demonstrating that hepatic soluble epoxide hydrolase (sEH) promotes osteoclastogenesis by inhibiting the Nrf2 signaling pathway. These results highlight redox imbalance as a mechanistic driver of bone loss and suggest new research avenues for targeting sEH-Nrf2 interactions in bone disease.

• Oligo (dT) 25 Beads: Technical Guidance for mRNA Purificatio

  2026-05-26

  Oligo (dT) 25 Beads are designed for efficient, selective eukaryotic mRNA isolation by targeting the polyA tail, supporting high-purity results for molecular biology workflows. They are best suited for applications requiring intact mRNA, such as RT-PCR, cDNA synthesis, and sequencing. These beads are not intended for prokaryotic RNA isolation or workflows that require total RNA without polyA selection.

• Nystatin (Fungicidin): Antifungal Mechanism, Evidence, and L

  2026-05-26

  Nystatin (Fungicidin) is a polyene antifungal effective against major Candida species and mycoplasma. Its mechanism involves ergosterol binding and membrane disruption. Recent evidence refines its spectrum and clarifies boundaries in viral inhibition.

16070 records 1/1072 page Next 12345 下5页 Last page